Comparison of Fracture Risk Following Semaglutide Treatment vs Sleeve Gastrectomy

Jairo A Noreña1, C William Pike2, Gavin Hui2

  • 1Division of Endocrinology, Gerontology and Metabolism, Stanford University School of Medicine, Palo Alto, California.

PubMed
Summary

Patients with obesity treated with semaglutide had a 26% lower fracture risk compared to those who underwent sleeve gastrectomy (SG). This finding suggests semaglutide may mitigate weight loss-associated fracture risks.